While Itzhaki’s work posits that the presence of HSV1 in the brain could precipitate AD, especially when coupled with genetic vulnerabilities such as the ApoE4 allele [42], our study extends this viral hypothesis to the realm of PD, underscoring a potential sex-specific risk modulation in the context of antiviral interventions. This evidence concerns the gene APOE and Parkinson disease.